Sal Trading, LLC Astrazeneca PLC Put Options Transaction History

Sal Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 07, 2024	BUY	$61.03 - $69.57 $768,978 - $876,581	12,600 Added 106.78%	24,400 $1.65 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $730,302 - $817,504	11,800 New	11,800 $794,000
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $13.9 Million - $15 Million	198,300 New	198,300 $14.2 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $1.77 Million - $2.12 Million	-29,800 Reduced 86.63%	4,600 $308,000
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $1.92 Million - $2.31 Million	34,400 New	34,400 $2.31 Million

1,349

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Sal Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Sal Trading, LLC with notifications on news.